Bill
HB 3057
Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
89th Legislature (2025)
Introduced by Adam Hinojosa and 2 co-sponsors
Texas mandates health insurance coverage of CAR-T cell cancer therapy without prior authorization delays, ensuring patient access to expensive immunotherapy starting September 2025.
Effective on 9/1/25
#cancer(s0658)
#health&humanservicescommission(v0177)
#health--children'sinsurance(i0388)
#health--otherdiseases&medicalconditions(i0383)
#insurance
#commissionerof(v0396)
#insurance--health&accident(i0422)
#medicaid(s4885)